Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,501.65 -12.72 -0.08%
S&P 500 1,875.39 -4.16 -0.22%
NASDAQ 4,126.97 -34.49 -0.83%
Ticker Volume Price Price Delta
STOXX 50 3,175.97 -23.72 -0.74%
FTSE 100 6,674.74 -7.02 -0.11%
DAX 9,544.19 -55.90 -0.58%
Ticker Volume Price Price Delta
NIKKEI 14,404.99 -141.28 -0.97%
TOPIX 1,164.90 -8.91 -0.76%
HANG SENG 22,529.29 19.65 0.09%

Baxter Declares Quarterly Dividend



  Baxter Declares Quarterly Dividend

Business Wire

DEERFIELD, Ill. -- November 13, 2012

The Board of Directors of Baxter International Inc. (NYSE:BAX) today declared
a quarterly dividend of $0.45 per Baxter common share. The dividend is payable
on January 3, 2013 to shareholders of record as of December 7, 2012.

This represents an annual dividend rate of $1.80 per share. In July, Baxter
increased its dividend rate 34 percent.

Baxter continues to generate strong cash flow and has returned significant
value to shareholders in the form of dividends and share repurchases. Over the
last five years (2007-2011), Baxter has generated an average of $2.7 billion
in cash flow annually and has returned more than $11.4 billion cumulatively to
shareholders through dividends and share repurchases.

Baxter International Inc., through its subsidiaries, develops, manufactures
and markets products that save and sustain the lives of people with
hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and
other chronic and acute medical conditions. As a global, diversified
healthcare company, Baxter applies a unique combination of expertise in
medical devices, pharmaceuticals and biotechnology to create products that
advance patient care worldwide.

This release includes forward-looking statements concerning the company's
dividend. The statements are based on assumptions about many important
factors, including the following, which could cause actual results to differ
materially from those in the forward-looking statements: continued strength in
the company’s financial position, including cash flows; future decisions of
the board of directors of the company to continue payments to shareholders in
the form of a dividend on a quarterly or other basis relative to alternative
uses of funds; and other risks identified in the company's most recent filing
on Form 10-K and other SEC filings, all of which are available on the
company's website. The company does not undertake to update its
forward-looking statements.

Contact:

Baxter International Inc.
Media Contact:
Deborah Spak, (224) 948-2349
or
Investor Contacts:
Mary Kay Ladone, (224) 948-3371
Clare Trachtman, (224) 948-3085
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement